WaferGen Biosystems Reports Q3 '13 Results And Commercial Focus On Target Enrichment For Next-Gen Sequencing (NGS)

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

FREMONT, Calif., Nov. 14, 2013 /PRNewswire via COMTEX/ -- WaferGen Bio-systems, Inc. (otcqb:WGBS) announced today its financial results for the third quarter ended September 30, 2013.

Total revenue for the third quarter of 2013 was $390,000, up 121% from $177,000 in the third quarter of 2012. Net loss for the third quarter of 2013 was $11.0 million, compared to a net loss of $3.0 million in the third quarter of 2012.

Help employers find you! Check out all the jobs and post your resume.

Back to news